Showing results (341-350 of 446) with videos related to

Sort By:
Pageof 45
Gastroenterology|July 18, 2013
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseasePaul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, et al.
Gastroenterology|October 13, 2006
Utility of a new model to diagnose an alcohol basis for steatohepatitisWinston Dunn, Paul Angulo, Schuyler Sanderson, et al.
Hepatology (Baltimore, Md.)|September 5, 2022
Geographical similarity and differences in the burden and genetic predisposition of NAFLDTerry Cheuk-Fung Yip, Eduardo Vilar-Gomez, Salvatore Petta, et al.
Hepatology (Baltimore, Md.)|May 6, 2018
Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled TrialCatherine Properzi, Therese A O'Sullivan, Jill L Sherriff, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 19, 2013
Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesityTherese A OʼSullivan, Wendy H Oddy, Alexandra P Bremner, et al.
Journal of Gastroenterology and Hepatology|December 17, 2024
Natural History and Predictors of Clinical Outcomes in Autoimmune Liver Diseases: A Multicenter StudyDujinthan Jayabalan, Yi Huang, Luis Calzadilla-Bertot, et al.
Journal of Gastroenterology and Hepatology|February 10, 2020
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolizationMichael C Wallace, Shaun Samuelson, Tiffany Khoo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2026
Internal validation of the Hepascore and Liver Outcome Score for predicting clinical outcomes in autoimmune hepatitis and primary sclerosing cholangitis: a multi-centre studyDujinthan Jayabalan, Luis Calzadilla-Bertot, Yi Huang, et al.
Anticancer Research|July 4, 2012
The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatmentRoberto Gedaly, Paul Angulo, Changguo Chen, et al.
Pageof 45